Choroid Disease
10
0
0
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
0.0%
0 terminated out of 10 trials
100.0%
+13.5% vs benchmark
10%
1 trials in Phase 3/4
40%
2 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (10)
Dyadic Management Intervention in Older People With Co-occurring Cognitive Impairment and Diabetes as a Supplementary Approach to Chronic Diseases Self-Management Program
Multimodal Analysis and Electroretinogram in VKH From Acute Onset - Part I
Measuring Choroidal Thickness Using Optical Coherence Tomography
Ophthalmologic Outcomes in Patients With Carotid Artery Stenosis
The Effect of Intracameral Carbachol and Epinephrine on Choroidal Thickness
Choroidal Change on OCTA in Eyes With High Myopia
Treatment of Polypoidal Choroidal Vasculopathy in Pachychoroid
Changes of Macular Pigment and Parameters of Eyes After YAG Laser Treatment in Cases With Capsule Opacification
Study of Changes in Retrofoveolar Choroidal Thickness During Aerobic Exercise
The Effects of α-adrenergic Receptor Antagonists on Choroid and Pupil